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Vascular closure devices have been shown to decrease hemostasis and ambulation time after percutaneous transcatheter
procedures. The StarClose Vascular Closure System (Abbott Vascular, Redwood City, Calif) is a shape memory
clip–mediated device that is designed to provide extraluminal mechanical closure without compromising the arterial
lumen.We report a case of iatrogenic arterial occlusion secondary tomechanical closure of the anterior and posterior walls
of the common femoral artery with a StarClose device. We provide objective observations from the rescue surgical
intervention and discuss potential mechanisms of device failure. ( J Vasc Surg 2008;48:469-71.)Vascular closure devices (VCDs) are frequently used
after diagnostic and interventional percutaneous proce-
dures. Studies have shown that the use of VCDs, in contrast
to manual compression, decreases the time to ambulation
and hemostasis.1-3 Unfortunately, VCD adverse events can
occur with significant short- and long-term implications.4-8
There are currently no prospective randomized trials to
show a reduction in arterial-related events comparing stan-
dard compression therapy and VCDs.
The StarClose Vascular Closure System (Abbott Vas-
cular, Redwood City, Calif) is a clip-mediated VCD that is
designed to provide extraluminal mechanical closure of an
arterial defect. The Clip Closure in Percutaneous Proce-
dures (CLIP) study demonstrated noninferior results when
the StarClose device was compared with manual compres-
sion, with none of the interventional or diagnostic cases
experiencing abrupt closure.2,9 We report a case of acute
limb ischemia after placement of a StarClose device after
diagnostic coronary angiography.
CASE REPORT
A 51-year-old woman with known hyperlipidemia, diabetes
mellitus, and hypertension presented to the emergency depart-
ment with a 48-hour history of diaphoresis and nausea with
vomiting. An electrocardiogram showed ST elevations in leads V1
and V2, and serial troponin enzymes were suggestive of myocardial
infarction. The patient subsequently underwent coronary angiog-
raphy and was found to have a 90% ostial narrowing of the second
diagonal branch and mild diffuse three-vessel disease. A small area
of akinesis in the second diagonal distribution was noted, but
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The catheterization was completed without incident, and after
ipsilateral oblique femoral angiographic confirmation of middle
anterior wall through a common femoral access, a StarClose device
was deployed with immediate hemostasis. The deployment se-
quence included exchanging a 5F sheath with the StarClose
sheath. The StarClose delivery shaft was then inserted into the
StarClose sheath until the shaft and sheath “clicked,” after the
guidewire was removed. The shaft was held with the right hand and
on the end of the shaft, the vessel locater was deployed by pressing
the U-shaped button on the end of the shaft. The trigger on the
inferior surface of the shaft is squeezed half way down to the skin,
which split the sheath to this level.
The shaft of the device was then maintained in the same angle
as the tissue track and the shaft withdrawn until resistance was met
with the vessel locater (located at the tip of the device within the
artery) and the intima of the artery. The trigger was then com-
pletely pulled to finalize the sheath split. The shaft was then raised
between 60° and 75°, and the was clip deployed by pushing the
button on the left side of the shaft while applying slight forward
pressure to allow the clip to capture the adventitia. The shaft was
then removed and light pressure held for 2 minutes. The cardiol-
ogist had previously performed 100 cases without a complica-
tion.
After arrival to the floor, the patient’s right foot was cool, with
decreased ipsilateral pedal pulses. Our team was consulted. An
examination found the patient’s left lower extremity had palpable
pulses at the ankle level, but the right lower extremity had nonpal-
pable pulses from the groin to the ankle. Noninvasive studies
suggested right external iliac artery/common femoral artery occlu-
sion.
In the angiography suite, the patient was evaluated for exter-
nal iliac dissection and baseline ipsilateral circulation before surgi-
cal intervention. A right common femoral artery occlusion was
confirmed by selective angiography from a contralateral access,
without evidence of iliac artery dissection (Fig 1). The left groin
sheath was removed and manual compression was performed.
Treatment of the common femoral occlusion was not entertained
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The patient was taken to the operating room where the
femoral artery was exposed with a vertical groin incision. The
StarClose device was found deployed in the anterior wall of
the common femoral artery; however, the “tines” had also attached
to the posterior wall of the common femoral artery, effectively
causing occlusion of the artery proper (Fig 2). The device was
removed from the artery, and patch angioplasty was performed
using the proximal great saphenous vein. Subsequently the patient
did well, with return of normal pulses to her lower extremity.
DISCUSSION
Complications related to femoral artery closure devices
are well known. Arterial laceration secondary to an anchor
device rupturing an artery has been reported, but this is a
rare complication.4 The two most common complications
are infection and ischemia. Infection-related groin compli-
cations include groin abscess,7 mycotic pseudoaneurysm,7
and endarteritis.10,11 The preponderance of infection-
related complications have occurred in suture-7,8,10,12 and
Fig 1. Angiography demonstrates a right common femoral artery
occlusion (arrow) with reconstitution of the deep femoral and
superficial femoral artery.collagen-11,12 mediated closure devices. We found no re-ports of StarClose infectious complications, and this is
consistent with the anticipated lower infection risk of metal
clip–based closure systems compared with the suture- and
collagen-based systems.
The second well-known complication related to VCDs
is limb ischemia. Acute limb ischemia4-6,12,13 secondary to
arterial occlusion and intermittent claudication13,14 sec-
ondary to arterial stenosis have both been reported. The
risk of limb ischemia is theoretically decreased with the use
of an extravascular clip compared with intravascular VCDs.
To our knowledge, only one report has been published of a
StarClose device causing acute limb ischemia, and this was
secondary to external iliac artery occlusion.15 The authors
concluded that the nitinol clip caused luminal narrowing
leading to arterial thrombosis. There is also a report of
significant claudication resulting from severe stenosis of the
superficial femoral artery related to intravascular deploy-
ment of a StarClose device.16
Treatment of arterial insufficiency secondary to vascular
closure devices can be managed be endovascular or surgical
intervention. If thrombosis occurs secondary to femoral
artery occlusion, surgical intervention provides a long-term
durable solution that usually requires endarterectomy and
removal of the VCD, with or without patch angioplasty. In
the acute setting, we advocate surgical intervention unless
the patient is at high risk of surgical complications second-
ary to comorbidities. There have been case reports of
endovascular techniques used to treat complications, in-
cluding atherectomy with filter embolic protection and
cutting balloon angioplasty to treat acute and late compli-
cations; however, these can be complex interventions with
the potential of adverse events.17,18
There has not been a previous publication of arterial
Fig 2. Vertical arteriotomy and resection of macerated anterior
wall was performed. The nitinol clip from the StarClose device was
attached to the posterior wall of the common femoral artery, with
residual anterior wall attached.occlusion secondary to the StarClose device capturing the
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presented here was relatively young, and the anterior wall of
the common femoral artery was soft with an associated hard
posterior plaque. If too much forward pressure is applied
during the delivery of the device, then compression of the
artery can occur with the risk of “capturing” the back wall
of the artery, which is what we believe occurred in this
patient. This can be prevented by applying only light for-
ward pressure when deploying the device and by taking
extra precautions in young patients with relatively soft
common femoral arteries. However, light forward pressure
is subjective and part of the learning curve, in which device
failure may occur if forward pressure is not adequately
applied and the clip may be deployed into the extravascular
soft tissue.
Our stance on the use of VCDs is overall a conservative
one. With previous meta-analysis providing evidence that
pseudoaneurysm formation and groin hematoma are not
reduced with VCD use, we reserve their use in patients who
are at risk for compression failures.19 We do believe there is
a role for the use of VCDs, but overall, restrict their use to
select circumstances, such as in patients who require con-
tinued anticoagulation, a body habitus (obese patients with
large pannus) that makes compression difficult, and in
patients with conditions such as back or neck disorders that
limit their ability to maintain a supine position for 4 to 6
hours.
The StarClose device is indicated for only maximum
sheath size of 6F. As sheath size increases to larger than 9F,
we recommend either suture-mediated closure devices
or surgical cutdown. We have used the Perclose suture-
mediated device (Abbott Vascular) when sheath sizes are
9F or larger, although the indication for use recommends
maximum sheath size of 8F.20
Routine angiography before deployment of a VCD is
imperative. This should include an ipsilateral oblique fem-
oral artery angiogram to identify the ostia of the superficial
and deep femoral arteries. Vascular closure devices are
contraindicated in small (5 mm) common femoral arter-
ies, high punctures (above the inguinal ligament), or low
punctures (deep or superficial femoral arteries). Ultrasound-
guided puncture of the common femoral artery can be used
to ensure anterior wall puncture and avoid sheath place-
ment in the deep femoral artery or superficial femoral
artery.
CONCLUSION
We do believe a subset of patients can benefit from the
use of VCDs and that VCDs can be used safely, but it is
important to recognize high-risk punctures where manual
compression should be used. In addition, there should be a
consideration for informed consent for these devices, be-
cause most patients may be unaware of their placement and
the unique adverse event risk until the procedure is com-
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